EUVIMEDAtklāt EUVIMED
Crossref

Renal transporter OAT1 and PPAR ‐α pathway co‐contribute to icaritin‐induced nephrotoxicity

Dalong Wang, Jing Liu, Xiaodong Chen, Jing Chen, Tingting Zhao, Jie Du, Changyuan Wang, Qiang Meng iD, Huijun Sun iD, Fangjun Wang, Kexin Liu, Jingjing Wu iD

Phytotherapy Research · 2023-02 · 37 (2) · 549-562

DOI: 10.1002/ptr.7633 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2022-11-04. Written by Dalong Wang and 11 co-authors. Institution: College of Pharmacy, Dalian Medical University, Dalian, China. Major MEDLINE topics: Peroxisome Proliferator-Activated Receptors, Proteomics. Cited 10 times so far (Crossref); 39 references. Funded by: Liaoning Revitalization Talents Program, National Natural Science Foundation of China.

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

This study aimed to investigate the potential nephrotoxicity of icaritin and the underlying mechanism by in vitro – in vivo experiment technology combined with proteomics technology. First, icaritin showed a significant cytotoxic effect on HK‐2 cells, which was accompanied by increased LDH and TNF‐α in the supernatant, decreased protein expressions of Bcl‐2 and increased Bax and enhanced apoptosis of HK‐2 cells as measured by TUNEL staining. Moreover, icaritin induced obvious tubular damage and up‐regulation of BUN and CRE levels in plasma in mice. Second, intracellular uptake of icaritin was considerably higher in hOAT1‐HEK293 cells than in mock‐HEK293 cells, suggesting that icaritin might accumulate in renal cells via OAT1 uptake. Importantly, icaritin caused significant changes in the PPAR signaling pathway in HK2 cells through proteomic analysis. Then, in vitro and in vivo results verified that icaritin significantly downregulated the protein expression of PPAR‐α as well as downregulated APOB, ACSL3, ACSL4, and upregulated 5/12/15‐HETE, implying that a lipid metabolism disorder was involved in the icaritin‐induced nephrotoxicity. Finally, icaritin was found to increase the accumulation of iron and LPO levels while reducing the activity of GPX4, suggesting that ferroptosis was involved in the nephrotoxicity induced by icaritin.

Subjects

MeSH terms (MEDLINE)

Peroxisome Proliferator-Activated ReceptorsProteomicsHumansMiceAnimalsHEK293 CellsKidneyApoptosisFlavonoids

Author keywords

FerroptosisIcaritinOAT1PPAR-αnephrotoxicity

Substances

Peroxisome Proliferator-Activated ReceptorsicaritinFlavonoids

Authors and institutions

  • College of Pharmacy, Dalian Medical University, Dalian, China.
  • Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning Dalian Medical University, Dalian, China.
  • School of Chemistry and Materials Science, University of Science and Technology of China, Hefei, China.
  • Key Laboratory of Separation Sciences for Analytical Chemistry, Chinese Academy of Sciences, Dalian, China.

ORCID profiles: Qiang Meng, Huijun Sun, Jingjing Wu

Funding

  • Liaoning Revitalization Talents Program
  • National Natural Science Foundation of China

Cite

APA

Wang, D., Liu, J., Chen, X., Chen, J., Zhao, T., Du, J., Wang, C., Meng, Q., Sun, H., Wang, F., Liu, K., & Wu, J. (2023). Renal transporter OAT1 and PPAR ‐α pathway co‐contribute to icaritin‐induced nephrotoxicity. Phytotherapy Research, 37(2), 549-562. https://doi.org/10.1002/ptr.7633

Vancouver

Wang D, Liu J, Chen X, Chen J, Zhao T, Du J, et al. Renal transporter OAT1 and PPAR ‐α pathway co‐contribute to icaritin‐induced nephrotoxicity. Phytotherapy Research. 2023;37(2):549-562. doi:10.1002/ptr.7633

BibTeX
@article{Wang2023,
  author = {Wang, Dalong and Liu, Jing and Chen, Xiaodong and Chen, Jing and Zhao, Tingting and Du, Jie and Wang, Changyuan and Meng, Qiang and Sun, Huijun and Wang, Fangjun and Liu, Kexin and Wu, Jingjing},
  title = {Renal transporter OAT1 and PPAR ‐α pathway co‐contribute to icaritin‐induced nephrotoxicity},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {2},
  pages = {549--562},
  doi = {10.1002/ptr.7633}
}
Start for free →